Rigel Pharmaceuticals (RIGL) Return on Capital Employed: 2011-2025
Historic Return on Capital Employed for Rigel Pharmaceuticals (RIGL) over the last 13 years, with Sep 2025 value amounting to 0.91%.
- Rigel Pharmaceuticals' Return on Capital Employed rose 79.00% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year increase of 79.00%. This contributed to the annual value of 0.31% for FY2024, which is 60.00% up from last year.
- Per Rigel Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.91% for Q3 2025, which was down 8.55% from 1.00% recorded in Q2 2025.
- Rigel Pharmaceuticals' 5-year Return on Capital Employed high stood at 1.00% for Q2 2025, and its period low was -1.06% during Q3 2022.
- Moreover, its 3-year median value for Return on Capital Employed was -0.13% (2024), whereas its average is 0.07%.
- Per our database at Business Quant, Rigel Pharmaceuticals' Return on Capital Employed crashed by 99bps in 2022 and then soared by 113bps in 2025.
- Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Return on Capital Employed stood at -0.11% in 2021, then slumped by 82bps to -0.93% in 2022, then surged by 60bps to -0.33% in 2023, then spiked by 60bps to 0.27% in 2024, then surged by 79bps to 0.91% in 2025.
- Its Return on Capital Employed stands at 0.91% for Q3 2025, versus 1.00% for Q2 2025 and 0.43% for Q1 2025.